Molecule Information
General Information of the Molecule (ID: Mol00772)
Name |
Aminoglycoside (3'') (9) adenylyltransferase (AADA)
,Escherichia coli
|
||||
---|---|---|---|---|---|
Synonyms |
aadA; APX88_23745; APX88_23750; DAH22_24350; GFY34_19935; GFY34_26370; IT029_005230; IT029_005519
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
aadA7
|
||||
Sequence |
MSEKVPAEISVQLSQALNVIGRHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAPLND
AVRQALLVDLLEVSASPGQNKALRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAG IFEPATTDSDLAILLTKAKQHSVVLAGSAAKDLFSSVPESDLFKALADTLKLWNSPPDWA GDERNVVLTLSRIWYTAATGKIAPKDVAATWAMARLPAQHQPILLNAKRAYLGQEEDYLP ARADQVAALIKFVKYEAVKLLGASQ Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
DISM: Drug Inactivation by Structure Modification
Drug Resistance Data Categorized by Drug
Approved Drug(s)
4 drug(s) in total
Ampicillin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: Urinary tract infection | [1] | |||
Resistant Disease | Urinary tract infection [ICD-11: GC08.1] | |||
Resistant Drug | Ampicillin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli serogroup O11 | 1095705 | ||
Escherichia coli serogroup O17 | 1010800 | |||
Escherichia coli serogroup O73 | 2170725 | |||
Escherichia coli serogroup O77 | 562 | |||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Microdilution method assay | |||
Mechanism Description | All the UTI outbreak CgA strains in this study contained the same class 1 integron dfrA17-aadA5 gene cassette arrangement with 100% sequence match, suggesting clonal spread of the bacterial strain itself. While aminoglycoside adenyltransferase A (aadA ) and dihydrofolate reductase A (dfrA ), encoding resistance to streptomycin and trimethoprim. |
Ciprofloxacin XR
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: Urinary tract infection | [1] | |||
Resistant Disease | Urinary tract infection [ICD-11: GC08.1] | |||
Resistant Drug | Ciprofloxacin XR | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli serogroup O11 | 1095705 | ||
Escherichia coli serogroup O17 | 1010800 | |||
Escherichia coli serogroup O73 | 2170725 | |||
Escherichia coli serogroup O77 | 562 | |||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Microdilution method assay | |||
Mechanism Description | All the UTI outbreak CgA strains in this study contained the same class 1 integron dfrA17-aadA5 gene cassette arrangement with 100% sequence match, suggesting clonal spread of the bacterial strain itself. While aminoglycoside adenyltransferase A (aadA ) and dihydrofolate reductase A (dfrA ), encoding resistance to streptomycin and trimethoprim. |
Co-trimoxazole
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: Urinary tract infection | [1] | |||
Resistant Disease | Urinary tract infection [ICD-11: GC08.1] | |||
Resistant Drug | Co-trimoxazole | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli serogroup O11 | 1095705 | ||
Escherichia coli serogroup O17 | 1010800 | |||
Escherichia coli serogroup O73 | 2170725 | |||
Escherichia coli serogroup O77 | 562 | |||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Microdilution method assay | |||
Mechanism Description | All the UTI outbreak CgA strains in this study contained the same class 1 integron dfrA17-aadA5 gene cassette arrangement with 100% sequence match, suggesting clonal spread of the bacterial strain itself. While aminoglycoside adenyltransferase A (aadA ) and dihydrofolate reductase A (dfrA ), encoding resistance to streptomycin and trimethoprim. |
Gentamicin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Drug Inactivation by Structure Modification (DISM) | ||||
Disease Class: Urinary tract infection | [1] | |||
Resistant Disease | Urinary tract infection [ICD-11: GC08.1] | |||
Resistant Drug | Gentamicin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli serogroup O11 | 1095705 | ||
Escherichia coli serogroup O17 | 1010800 | |||
Escherichia coli serogroup O73 | 2170725 | |||
Escherichia coli serogroup O77 | 562 | |||
Experiment for Molecule Alteration |
PCR amplification and sequence alignments assay | |||
Experiment for Drug Resistance |
Microdilution method assay | |||
Mechanism Description | All the UTI outbreak CgA strains in this study contained the same class 1 integron dfrA17-aadA5 gene cassette arrangement with 100% sequence match, suggesting clonal spread of the bacterial strain itself. While aminoglycoside adenyltransferase A (aadA ) and dihydrofolate reductase A (dfrA ), encoding resistance to streptomycin and trimethoprim. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.